Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-028014

Chief Commercial Officer sold 25,000 shares at $22.19 ($554,693)

  • Chief Commercial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Maduck Sean Chief Commercial Officer 2021-07-07 Option exercise +25,000 $3.29 $82,250 55,024 D
Maduck Sean Chief Commercial Officer 2021-07-07 Sale −25,000 $22.19 $554,693 30,024 D
Derivatives
Maduck Sean Chief Commercial Officer 2021-07-07 Option exercise · Stock Option (Right to Buy) −25,000 197,602 D
Open-market sales · 25,000 sh · avg $22.19 · $554,693
Loading xslF345X03/doc4.xml…